These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7527728)

  • 1. [Mutation of p53 gene and expression of alphafetoprotein during hepatocarcinogenesis].
    Zou HQ; Tang ZY; Ye SL
    Zhonghua Yi Xue Za Zhi; 1994 Aug; 74(8):474-5, 517-8. PubMed ID: 7527728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of mutant p53 in chronic HBV infection and hepatocellular carcinoma].
    Chen Y; Tang ZY; Li J
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):184-7. PubMed ID: 7956695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of p53 in a large series of patients with hepatocellular carcinoma: a clinicopathological correlation.
    Caruso ML; Valentini AM
    Anticancer Res; 1999; 19(5B):3853-6. PubMed ID: 10628323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
    Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
    Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of HCV NS3 protein on expression of p53 gene protein in hepatocarcinogenesis].
    Feng D; Zheng H; Yan Y
    Zhonghua Yi Xue Za Zhi; 1998 Apr; 78(4):278-80. PubMed ID: 10923485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation.
    Huang LR; Hsu HC
    Cancer Res; 1995 Oct; 55(20):4717-21. PubMed ID: 7553654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-fetoprotein gene polymorphisms and risk of HCC and cirrhosis.
    Suriapranata IM; Sudania WM; Tjong WY; Suciptan AA; Gani RA; Hasan I; Sanityoso A; Budihusodo U; Miskad UA; Akil F; Lelosutan SA; Martamala R; Yusuf I; Lesmana LA; Sulaiman A; Tai S
    Clin Chim Acta; 2010 Mar; 411(5-6):351-8. PubMed ID: 19968979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C; Li Z; Cheng Y; Jia F; Li R; Wu M; Li K; Wei L
    Clin Cancer Res; 2007 Feb; 13(3):944-52. PubMed ID: 17289889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells.
    Arima T; Nakao K; Nakata K; Ishikawa H; Ichikawa T; Hamasaki K; Ishii N; Eguchi K
    Int J Mol Med; 2002 Apr; 9(4):397-400. PubMed ID: 11891535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.
    Volkmann M; Müller M; Hofmann WJ; Meyer M; Hagelstein J; Räth U; Kommerell B; Zentgraf H; Galle PR
    Hepatology; 1993 Sep; 18(3):559-65. PubMed ID: 7689531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma].
    Wang XH; Wang PL
    Ai Zheng; 2003 Jul; 22(7):715-8. PubMed ID: 12866962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent evaluation of p53, beta-catenin, and alpha-fetoprotein expression in human hepatocellular carcinoma.
    Torbenson M; Kannangai R; Abraham S; Sahin F; Choti M; Wang J
    Am J Clin Pathol; 2004 Sep; 122(3):377-82. PubMed ID: 15362367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness.
    Hsu HC; Tseng HJ; Lai PL; Lee PH; Peng SY
    Cancer Res; 1993 Oct; 53(19):4691-4. PubMed ID: 8402647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma.
    Anzola M; Saiz A; Cuevas N; Lopez-Martinez M; Martinez de Pancorbo MA; Burgos JJ
    J Viral Hepat; 2004 Nov; 11(6):502-10. PubMed ID: 15500550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [WAF1/CIP1 gene expression in human hepatocellular carcinoma and its relationship with p53 mutation].
    Zhu B; Cong W; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):217-20. PubMed ID: 10715791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Numerical aberrations of chromosome 17 and the p53 locus in small hepatocellular carcinomas.
    Yano H; Nanashima A; Hidaka S; Haseba M; Tanaka K; Yamaguchi H; Nakagoe T; Tagawa Y; Nagayasu T
    Anticancer Res; 2004; 24(1):111-5. PubMed ID: 15015584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.